Kisato Nosaka Selected Research

Cyclophosphamide (Cytoxan)

1/2021	A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial.
12/2020	Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
2/2015	Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study.
1/2014	Complete remission achieved in a multiple myeloma patient with elevated serum KL-6 level by a combination regimen with bortezomib, cyclophosphamide, and dexamethasone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kisato Nosaka Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 01/2009
15	Lymphoma (Lymphomas) 09/2023 - 01/2009
14	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2023 - 01/2002
5	Disease Progression 11/2023 - 01/2009
5	Multiple Myeloma 09/2023 - 01/2009
5	Infections 01/2023 - 09/2015
5	T-Cell Leukemia (Leukemia, T Cell) 10/2019 - 07/2010
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022 - 10/2020
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 09/2015
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2021 - 01/2009
3	Body Weight (Weight, Body) 05/2020 - 01/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2010 - 07/2007
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 01/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 03/2016
2	Edema (Dropsy) 01/2022 - 06/2016
2	Hepatitis 05/2021 - 09/2015
2	Pneumonia (Pneumonitis) 05/2020 - 01/2019
2	Thrombocytopenia (Thrombopenia) 06/2016 - 03/2016
2	Hematologic Neoplasms (Hematological Malignancy) 05/2012 - 01/2009
2	Residual Neoplasm 05/2012 - 01/2009
2	Carcinogenesis 07/2010 - 08/2005
1	Febrile Neutropenia 09/2023
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 07/2023
1	Chordoma 07/2023
1	COVID-19 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Hypertriglyceridemia 09/2021
1	Aspiration Pneumonia 09/2021
1	Bacteremia 11/2020
1	Melanoma (Melanoma, Malignant) 06/2020
1	Disseminated Intravascular Coagulation 06/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2020
1	Aphasia (Dysphasia) 05/2020

Drug/Important Bio-Agent (IBA)

8	mogamulizumabIBA 10/2022 - 03/2012
6	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 04/2004
6	Rituximab (Mabthera)FDA Link 05/2021 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2014
4	AntibodiesIBA 01/2020 - 01/2015
3	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2022 - 01/2009
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2021 - 09/2015
3	Antiviral Agents (Antivirals)IBA 05/2021 - 09/2015
3	Macrophage Colony-Stimulating FactorIBA 01/2019 - 01/2002
3	Lenalidomide (CC 5013)FDA Link 12/2016 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2009
2	Cefepime (Maxipime)FDA LinkGeneric 09/2023 - 05/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2015
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2014
2	ParaffinIBA 01/2022 - 01/2019
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2019
2	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 12/2020
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 12/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2020
2	LigandsIBA 01/2019 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 12/2010
2	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2018 - 01/2009
2	SteroidsIBA 06/2016 - 09/2015
2	CCR4 ReceptorsIBA 06/2015 - 03/2012
2	Bortezomib (Velcade)FDA Link 02/2015 - 01/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2015 - 01/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2010 - 01/2009
1	Brachyury protein (Brachyury)IBA 01/2024
1	Immune Checkpoint InhibitorsIBA 07/2023
1	cilgavimabIBA 01/2023
1	tixagevimabIBA 01/2023
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2023
1	PD 128042IBA 06/2022
1	LipidsIBA 06/2022
1	CholesterolIBA 06/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	tazemetostatIBA 09/2021
1	Surface Antigens (Surface Antigen)IBA 05/2021
1	lipoarabinomannan (LAM)IBA 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	Vindesine (Vindesin)IBA 12/2020
1	Carboplatin (JM8)FDA LinkGeneric 12/2020
1	ranimustineIBA 12/2020
1	Adenosine Monophosphate (AMP)IBA 12/2020
1	Etoposide (VP 16)FDA LinkGeneric 12/2020
1	Cefmetazole (Cefmetazole Sodium)FDA Link 11/2020
1	Cefazolin (Ancef)FDA LinkGeneric 11/2020
1	flomoxefIBA 11/2020
1	Cefotiam FDA Link 11/2020
1	IpilimumabIBA 06/2020
1	NivolumabIBA 06/2020
1	CreatinineIBA 05/2020
1	Vancomycin FDA LinkGeneric 05/2020

Therapy/Procedure

15	Therapeutics 11/2023 - 01/2009
11	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
4	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2009
3	Stem Cell Transplantation 10/2020 - 09/2018
2	Induction Chemotherapy 05/2021 - 10/2020
2	Molecular Targeted Therapy 05/2012 - 01/2009
1	Immunotherapy 07/2023
1	Cell Transplantation 03/2022
1	Autologous Transplantation 10/2020
1	Drug Tapering 05/2020